Literature DB >> 22248059

Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies.

B Bonavida1, S Huerta-Yepez, S Baritaki, M Vega, H Liu, H Chen, J Berenson.   

Abstract

The transcription factor Yin Yang (YY) 1 has been reported to be overexpressed in several tumor types and plays a role in both the progression of the disease as well as the maintenance of tumor cell resistance to cell death by cytotoxic drugs. YY1 also has been reported to be a prognostic factor for several cancers and was proposed to be a therapeutic target. The expression, function, and role of YY1 in the pathogenesis of hematologic malignancies are summarized briefly herein. Data are represented for B non-Hodgkin lymphoma, AIDS-related lymphoma, multiple myeloma, and children's acute lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22248059     DOI: 10.1615/critrevoncog.v16.i3-4.90

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  9 in total

1.  Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.

Authors:  Apostolos Zaravinos; Peggy Kanellou; George I Lambrou; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2014-01-31

Review 2.  Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Authors:  Nicholas R Galloway; Kathryn F Ball; TessaRae Stiff; Nathan R Wall
Journal:  Crit Rev Oncog       Date:  2017

3.  CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.

Authors:  Charalabos Pothoulakis; Monica Torre-Rojas; Marco A Duran-Padilla; Jonathan Gevorkian; Odysseas Zoras; Emmanuel Chrysos; George Chalkiadakis; Stavroula Baritaki
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.316

4.  Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study.

Authors:  Sameh Hafsi; Saverio Candido; Roberta Maestro; Luca Falzone; Zora Soua; Benjamin Bonavida; Demetrios A Spandidos; Massimo Libra
Journal:  Oncol Lett       Date:  2015-12-14       Impact factor: 2.967

5.  Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma.

Authors:  Jéssica Arribas Arranz; Dalia Nilufar Winter; Hans Günter Drexler; Sonja Eberth
Journal:  Biomark Res       Date:  2018-03-13

Review 6.  Application of computational methods for anticancer drug discovery, design, and optimization.

Authors:  Diego Prada-Gracia; Sara Huerta-Yépez; Liliana M Moreno-Vargas
Journal:  Bol Med Hosp Infant Mex       Date:  2016-11-30

Review 7.  Function of Deptor and its roles in hematological malignancies.

Authors:  Mario Morales-Martinez; Alan Lichtenstein; Mario I Vega
Journal:  Aging (Albany NY)       Date:  2021-01-07       Impact factor: 5.682

8.  Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Gabriela Antonio-Andres; Gustavo U Martinez-Ruiz; Mario Morales-Martinez; Elva Jiménez-Hernandez; Estefany Martinez-Torres; Tania V Lopez-Perez; Laura A Estrada-Abreo; Genaro Patino-Lopez; Sergio Juarez-Mendez; Víctor M Davila-Borja; Sara Huerta-Yepez
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

Review 9.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.